Xalkori Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

xalkori

pfizer europe ma eeig - crizotinib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.

Toviaz Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

toviaz

pfizer europe ma eeig - fesóteródín fúmarat - Þvagblöðru, ofvirk - Þvaglát - meðferð einkenna (aukinn tíðni og / eða brýnt þvaglát og / eða bráðatilfinning) sem getur komið fram hjá sjúklingum með ofvirkan þvagblöðruheilkenni.

MYDRANE Stungulyf, lausn 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

mydrane stungulyf, lausn 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml

laboratoires thea* - lidocainum hýdróklóríð; phenylephrinum hýdróklóríð; tropicamidum inn - stungulyf, lausn - 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml